Premature mortality due to cancer in Japan, 1995 and 2005
Premature mortality due to cancer in Japan, 1995 and 2005
复制标题
DOI：
10.1002/ijc.25021
复制
发表时间：
2010-07-01
影响因子：
6.4
通讯作者：
Yoshimura, Takesumi
中科院分区：
文献类型：
--
作者：
Pham, Truong-Minh;Fujino, Yoshihisa;Yoshimura, Takesumi
为了更好地了解癌症导致的过早死亡，我们根据日本人口统计局的数据，估计了1995年和2005年癌症导致的寿命损失年数（YLL）和平均寿命损失年数（AYLL）。在男性中，我们确定了1995年和2005年分别有159，623人和196，603人死于癌症。总YLL分别为2，342，560.4和2，724，066.0年。1995年，所有癌症的平均死亡时间比预期寿命短14.7年，2005年为13.9年。脑癌死亡的AYLL最长，比1995年的预期提前了26.3年，2005年提前了22.8年，其次是白血病。在妇女中，1995年共有103 399人死于癌症，2005年为129 338人。1995年和2005年的平均寿命分别为1，818，960.4年和2，160，706.5年，所有癌症的平均寿命分别为17.6年和16.7年。脑癌死亡的AYLL也是最长的，1995年为29.4年，2005年为27.8年，其次是白血病和女性性相关癌症。结果显示，在1995年和2005年，胃癌、结直肠癌、肝癌和肺癌是男女最常见的癌症，并导致了大量的YLL。此外，男性和女性的脑癌和白血病以及与性有关的女性癌症，即乳腺癌、宫颈癌和卵巢癌的AYLL最高。
To better understand premature mortality due to cancer, we estimated years of life lost (YLL) and average years of life lost (AYLL) due to cancer for the years 1995 and 2005, based on data from the Vital Statistic of japan. In men, we identified a total of 159,623 cancer deaths in 1995 and 196,603 in 2005. Total YLL were 2,342,560.4 and 2,724,066.0 years, respectively. Averaged for all cancers, people died 14.7 years earlier than life expectancy in 1995 and 13.9 years in 2005. AYLL was longest for brain cancer deaths, at 26.3 years earlier than expected in 1995 and 22.8 years in 2005, followed by leukemia. In women, a total of 103,399 cancer deaths occurred in 1995 and 129,338 in 2005. Total YLL were 1,818,960.4 years in 1995 and 2,160,706.5 years in 2005, corresponding to AYLL for all cancer combined of 17.6 and 16.7 years. The AYLL of brain cancer deaths was also the longest, at 29.4 years in 1995 and 27.8 in 2005, followed by leukemia and female sex-related cancers. Results showed that cancer of the stomach, colorectum, liver and lung were the most frequent cancers in both sexes in both 1995 and 2005 and responsible for a remarkable number of YLL. Further, AYLL was greatest for brain cancer and leukemia in both sexes and for sex-related cancers in women, namely breast, cervix and ovarian cancer.